IDRA   $7.1774  -1.47% Market Closed

Idera Pharmaceuticals Inc
Total Cash 24.48M
totalCashPerShare 0.461
EBITDA -19.49M
Total Debt 656.00K
quickRatio 5.169
currentRatio 5.404
Total Revenue
debtToEquity 3.104
Revenue/Share
ROA -0.34479
ROE -0.66496
grossProfits -9.25M
freeCashflow -9.51M
operatingCashflow -16.84M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -3.66M
forwardPE
floatShares 37.10M
sharesOutstanding 52.80M
sharesShort 668.03K
sharesShortPriorMonth 550.62K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.30%
heldPercentInstitutions 0.06%
Short Ratio help_outline 6.53%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.909
Price To Book help_outline 0.47
earningsQuarterlyGrowth
netIncomeToCommon -17.99M
trailingEps -3.56%
forwardEps -0.57%
enterpriseToEbitda 0.19
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2022
institutionsCount 35
lastUpdated March 20, 2023, 12:33 p.m.